FCER2 and B-cell chronic lymphocytic leukemia: The integrin expression was evident in CD23+ cells, a common CLL marker that promotes the activation and proliferation of normal B lymphocytes and has an important role in the process of malignant transformation in B-CLL [21,22,23].